Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Refael Yonatan-Leus, Maayan Abargil & Rena Cooper-Kazaz. (2022) The combined effect of psychodynamic psychotherapy and pharmacotherapy on healthcare cost. Psychotherapy Research 32:7, pages 874-885.
Read now
Read now
Rimal Bera, Steve Offord, Donna Zubek, Gina Lau, Jay Lin, Ross A. Baker & Craig Karson. (2013) Impact on healthcare resource usage and costs among Medicaid-insured schizophrenia patients after initiation of treatment with long-acting injectable antipsychotics. Journal of Medical Economics 16:4, pages 522-528.
Read now
Read now
Articles from other publishers (11)
Anthony J. Perkins, Rezaul Khandker, Ashley Overley, Craig A. Solid, Farid Chekani, Anna Roberts, Paul Dexter, Malaz A. Boustani & Leslie Hulvershorn. (2023) The impact of antipsychotic adherence on acute care utilization. BMC Psychiatry 23:1.
Crossref
Crossref
Rezaul Khandker, Jason Shepherd, Farid Chekani, Zaina Qureshi, Hollie Bailey, Mia Berry, Jack Wright & Lucy Massey. (2022) Atypical Treatment Switches in Schizophrenia Patients: Drivers and Associated Outcomes. Neuropsychiatric Disease and Treatment Volume 18, pages 1057-1067.
Crossref
Crossref
Christoph U. Correll, Kimberly E. Vanover, Robert E. Davis, Richard Chen, Andrew Satlin & Sharon Mates. (2021) Safety and tolerability of lumateperone 42 mg: An open-label antipsychotic switch study in outpatients with stable schizophrenia. Schizophrenia Research 228, pages 198-205.
Crossref
Crossref
Jitendra Rohilla, Pinki Tak, Shubham Jhanwar & Shazia Hasan. (2020) Primary care physician's approach for mental health impact of COVID-19. Journal of Family Medicine and Primary Care 9:7, pages 3189.
Crossref
Crossref
Soohyun Joe & Jung Sun Lee. (2016) Association between non-compliance with psychiatric treatment and non-psychiatric service utilization and costs in patients with schizophrenia and related disorders. BMC Psychiatry 16:1.
Crossref
Crossref
L. Alphs, D. Hough, P.B. Ryan & P.E. Stang. (2020) Étude comparant la subtitution de la rispéridone injectable à action prolongée par la palipéridone injectable à action prolongée versus une substitution par antipsychotiques oraux. European Psychiatry 29:S3, pages 658-658.
Crossref
Crossref
Sudeep Karve, Michael Markowitz, Dong-Jing Fu, Jean-Pierre Lindenmayer, Chi-Chuan Wang, Sean D. Candrilli & Larry Alphs. (2014) Assessing Medication Adherence and Healthcare Utilization and Cost Patterns Among Hospital-Discharged Patients with Schizoaffective Disorder. Applied Health Economics and Health Policy 12:3, pages 335-346.
Crossref
Crossref
Rimal Bera, Steve Offord, Donna Zubek, Gina Lau, Jay Lin & Craig Karson. (2014) Hospitalization Resource Utilization and Costs Among Medicaid Insured Patients With Schizophrenia With Different Treatment Durations of Long-Acting Injectable Antipsychotic Therapy. Journal of Clinical Psychopharmacology 34:1, pages 30-35.
Crossref
Crossref
Michael Markowitz, Sudeep Karve, Jessica Panish, Sean D Candrilli & Larry Alphs. (2013) Antipsychotic adherence patterns and health care utilization and costs among patients discharged after a schizophrenia-related hospitalization. BMC Psychiatry 13:1.
Crossref
Crossref
Robert C. WoodIIIIII, Stacy Miller, Marsha Dangler, Julie Horne & Adam Seneker. (2013) Psychiatric outcomes associated with citalopram dose reduction in veterans after food and drug administration warning. Mental Health Clinician 3:5, pages 251-255.
Crossref
Crossref
Chee Hong Ng, Deidre J Smith, Joel King, Susan Ong & Isaac Schweitzer. (2012) Medication attitudes and beliefs in patients with psychotic and affective disorders on maintenance treatment. Human Psychopharmacology: Clinical and Experimental 27:1, pages 57-62.
Crossref
Crossref